Podcast Index
Explora podcasts por categoría, abre episodios recientes y descarga audio para escucharlo sin conexión.
The Bio Report
Levine Media Group
New Books in Urban Studies
New Books Network
Exchanges: A Cambridge UP Podcast
New Books Network
The BoldlyGo Podcast: Revolutionizing Your Journey
DeAndre Coke
West Palm Beach Weather Daily
Fast Foundations
Montreal Weather Daily
Fast Foundations
Toronto Weather Daily
Fast Foundations
Philadelphia Weather Daily
Fast Foundations
Wanderer Chronicles Radio
Asa Bove Sobelow
Dark Mysteries — Unsolved Mysteries. Forgotten Secrets. Unanswered Questions.
Darkest Mysteries Online
Ologies with Alie Ward
Alie Ward
Artificial Intelligence Masterclass
AI Masterclass
Quazi Johir
Quazi Johir
Straight From The Cutter's Mouth: A Retina Podcast
Jayanth Sridhar
Crazy Town
Post Carbon Institute
Terrain Theory
Terrain Theory Ben
The Wood Hounds
The Wood Hounds
Dietetics with Dana
Dana J. Fryer, MS, RDN, CNSC
Chicago Weather Daily
Fast Foundations
Clima Diario Ciudad de México
Fast Foundations
Time and Tide
New Hampshire Sea Grant
Neville Goddard Daily
Neville Goddard
Daily Short Stories - Ghost and Horror Stories
Sol Good Network
Daily Science Fiction Stories
solgoodmedia.com
Science Fiction - Daily Short Stories
Sol Good Network
Stories - Science Fiction
Sol Good Network
Daily Ghost and Horror Stories
solgoodmedia.com
SciFi Cast
solgoodmedia.com
Mind Webs Radio
solgoodmedia.com
Quiet Please
Wyllis Cooper
Mind Webs
solgoodmedia.com
The Adventures of Superman
Dashiell Hammett
Classic Radio Science Fiction
solgoodmedia.com
Science Fiction Radio Hour
solgoodmedia.com
Interstellar Sci-Fi Tunes
solgoodmedia.com
Time Traveler's Radio
solgoodmedia.com
Science Fiction Radio
solgoodmedia.com
Ciencia
Levine Media Group
Acute ischemic stroke is both ubiquitous and undertreated. Only a small fraction of patients currently receive clot-busting drugs or mechanical thrombectomy because of the small treatment window. That’s because existing ...
Plasma gelsolin is an abundant, endogenous regulator of inflammation that is consumed during severe inflammatory insults. When levels fall too low, patients are at higher risk of organ damage and death, particularly in s...
A chronic shortage of high‑quality targets remains one of the biggest constraints in drug discovery, even as therapeutic tools become more powerful and diverse. Regeneron is tackling that problem with its Regeneron Genet...
Epigenetics, the layer of chemical switches that controls how genes are turned on and off, can act like cancer’s operating system when a single epigenetic enzyme becomes essential for a tumor to survive. K36 Therapeutics...
Most marketed antibodies work as antagonists, simply shutting off a receptor, even though many immune, metabolic, and cancer pathways require more nuanced control. Metaphore Biotechnologies' function‑first platform combi...
Cells continuously sense their environment and in response to stressors, adapt, recover, or die. Soley Therapeutics uses its AI platform to capture thousands of intracellular features and map how cells sense, interpret, ...
Promising drugs can become abandoned or underused because of tolerability issues, poor drug‑like properties, or other fixable limitations, even when there is already compelling human evidence that they work. PureTech Hea...
Most cancer therapies hit one or a few pathways that tumors can escape by mutating, activating alternative survival routes, or pumping drugs out, leading to relapse and poor survival in indications such as liver, ovarian...
Gout may be one of the oldest known forms of arthritis, but it remains widely misunderstood, undertreated, and a source of silent suffering for millions of people who are often blamed for their disease rather than offere...
Small molecule drugs and monoclonal antibodies often fall short at addressing severe inflammatory and immune‑mediated diseases. Mesoblast has spent more than 15 years industrializing mesenchymal stromal cell therapies to...
Most existing therapies for multiple sclerosis do a good job of reducing relapses and inflammatory activity, but they largely fail to stop the slow neurodegeneration that drives long-term disability, especially in progre...
The treatment of inflammatory bowel disease currently relies on immunosuppressive therapies that often lose effectiveness, carry infection risks, and drive high treatment cycling. Abivax is betting that fine-tuning, rath...
Many people with the genetic condition Lynch syndrome live with the near‑certainty that they will one day develop cancer and have few options beyond constant screening and, in some cases, preventive surgery. Nouscom is t...
Alzheimer’s disease drug development has long focused on slowing memory loss, but for many families, the tipping point that makes home care impossible is not cognition—it is psychosis. Hallucinations and delusions in Alz...
RICO, the Racketeer Influenced and Corrupt Organizations Act, was originally designed to prosecute organized crime. Today, it sits at the center of a landmark class action against two of the world’s largest pharmaceutica...
Pancreatic cancer remains one of oncology’s deadliest diagnoses, with standard treatments often offering only transient tumor shrinkage at the cost of grueling side effects and rapid resistance. Immuneering is using tran...
Human leukocyte antigen, or HLA, genes, help the immune system tell the difference between the body’s own tissues and outside threats. In some people, certain versions of HLA genes mistakenly flag normal proteins as dang...
Asia is quickly becoming a powerhouse for biopharma innovation, changing ideas about where breakthrough science and fast, cost-efficient drug development happen. A new McKinsey & Company report shows how countries like C...
Leukemia once threatened Aaron Viny’s life, but now it defines his mission. Diagnosed with acute lymphoblastic leukemia as a college student, he survived chemotherapy, central nervous system relapse, and an allogeneic st...
When Amy Burroughs stepped in as CEO of Terns Pharmaceuticals, she not only had to fill a void created by the death of her predecessor, but also lead a strategic shift from an increasingly crowded area of metabolic disea...
Completa el formulario de abajo. Asegúrate de seleccionar tanto País como Géneros.
Envíanos un mensaje abajo. Te responderemos en un plazo de 24 horas.